Rituximab or cyclophosphamide in the treatment of membranous nephropathy: the RI-CYCLO randomized trial

F Scolari, E Delbarba, D Santoro… - Journal of the …, 2021 - journals.lww.com
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a …
被引用次数：134 相关文章

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro, L Gesualdo… - JOURNAL OF THE …, 2021 - iris.unibs.it
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a …

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro, L Gesualdo… - Journal of the American …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Significance Statement</jats: title>< jats: p> A cyclic regimen of
corticosteroid and cyclophosphamide is the first-line therapy for membranous nephropathy …
[HTML] nih.gov

[HTML][HTML] Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO
Randomized Trial - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro, L Gesualdo… - JOURNAL OF THE …, 2021 - iris.unica.it
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a …

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro… - JOURNAL OF THE …, 2021 - ricerca.uniba.it
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO
Randomized Trial IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie …

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a …

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro, L Gesualdo… - JOURNAL OF THE …, 2021 - iris.unime.it
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a …

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro, L Gesualdo… - JOURNAL OF THE …, 2021 - iris.uniupo.it
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO
Randomized Trial IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie …

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

F Scolari, E Delbarba, D Santoro… - JOURNAL OF THE …, 2021 - iris.unimore.it
Background A cyclic corticosteroid-cyclophosphamide regimen is the first-line therapy for
membranous nephropathy. Compared with this regimen, rituximab therapy might have a …